Cargando…
Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity
Accumulating evidence indicates that metabolic dysfunction with visceral obesity is a major medical problem associated with the development of hypertension, type 2 diabetes (T2DM) and dyslipidemia, and ultimately severe cardiovascular and renal disease. Therefore, an effective anti-obesity treatment...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794018/ https://www.ncbi.nlm.nih.gov/pubmed/24130717 http://dx.doi.org/10.1371/journal.pone.0075560 |
_version_ | 1782287165234872320 |
---|---|
author | Azushima, Kengo Tamura, Kouichi Wakui, Hiromichi Maeda, Akinobu Ohsawa, Masato Uneda, Kazushi Kobayashi, Ryu Kanaoka, Tomohiko Dejima, Toru Fujikawa, Tetsuya Yamashita, Akio Toya, Yoshiyuki Umemura, Satoshi |
author_facet | Azushima, Kengo Tamura, Kouichi Wakui, Hiromichi Maeda, Akinobu Ohsawa, Masato Uneda, Kazushi Kobayashi, Ryu Kanaoka, Tomohiko Dejima, Toru Fujikawa, Tetsuya Yamashita, Akio Toya, Yoshiyuki Umemura, Satoshi |
author_sort | Azushima, Kengo |
collection | PubMed |
description | Accumulating evidence indicates that metabolic dysfunction with visceral obesity is a major medical problem associated with the development of hypertension, type 2 diabetes (T2DM) and dyslipidemia, and ultimately severe cardiovascular and renal disease. Therefore, an effective anti-obesity treatment with a concomitant improvement in metabolic profile is important for the treatment of metabolic dysfunction with visceral obesity. Bofu-tsu-shosan (BOF) is one of oriental herbal medicine and is clinically available to treat obesity in Japan. Although BOF is a candidate as a novel therapeutic strategy to improve metabolic dysfunction with obesity, the mechanism of its beneficial effect is not fully elucidated. Here, we investigated mechanism of therapeutic effects of BOF on KKAy mice, a model of human metabolic disorders with obesity. Chronic treatment of KKAy mice with BOF persistently decreased food intake, body weight gain, low-density lipoprotein cholesterol and systolic blood pressure. In addition, both tissue weight and cell size of white adipose tissue (WAT) were decreased, with concomitant increases in the expression of adiponectin and peroxisome proliferator-activated receptors genes in WAT as well as the circulating adiponectin level by BOF treatment. Furthermore, gene expression of uncoupling protein-1, a thermogenesis factor, in brown adipose tissue and rectal temperature were both elevated by BOF. Intriguingly, plasma acylated-ghrelin, an active form of orexigenic hormone, and short-term food intake were significantly decreased by single bolus administration of BOF. These results indicate that BOF exerts a combinatorial favorable metabolic modulation including antihypertensive effect, at least partially, via its beneficial effect on adipose tissue function and its appetite-inhibitory property through suppression on the ghrelin system. |
format | Online Article Text |
id | pubmed-3794018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37940182013-10-15 Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity Azushima, Kengo Tamura, Kouichi Wakui, Hiromichi Maeda, Akinobu Ohsawa, Masato Uneda, Kazushi Kobayashi, Ryu Kanaoka, Tomohiko Dejima, Toru Fujikawa, Tetsuya Yamashita, Akio Toya, Yoshiyuki Umemura, Satoshi PLoS One Research Article Accumulating evidence indicates that metabolic dysfunction with visceral obesity is a major medical problem associated with the development of hypertension, type 2 diabetes (T2DM) and dyslipidemia, and ultimately severe cardiovascular and renal disease. Therefore, an effective anti-obesity treatment with a concomitant improvement in metabolic profile is important for the treatment of metabolic dysfunction with visceral obesity. Bofu-tsu-shosan (BOF) is one of oriental herbal medicine and is clinically available to treat obesity in Japan. Although BOF is a candidate as a novel therapeutic strategy to improve metabolic dysfunction with obesity, the mechanism of its beneficial effect is not fully elucidated. Here, we investigated mechanism of therapeutic effects of BOF on KKAy mice, a model of human metabolic disorders with obesity. Chronic treatment of KKAy mice with BOF persistently decreased food intake, body weight gain, low-density lipoprotein cholesterol and systolic blood pressure. In addition, both tissue weight and cell size of white adipose tissue (WAT) were decreased, with concomitant increases in the expression of adiponectin and peroxisome proliferator-activated receptors genes in WAT as well as the circulating adiponectin level by BOF treatment. Furthermore, gene expression of uncoupling protein-1, a thermogenesis factor, in brown adipose tissue and rectal temperature were both elevated by BOF. Intriguingly, plasma acylated-ghrelin, an active form of orexigenic hormone, and short-term food intake were significantly decreased by single bolus administration of BOF. These results indicate that BOF exerts a combinatorial favorable metabolic modulation including antihypertensive effect, at least partially, via its beneficial effect on adipose tissue function and its appetite-inhibitory property through suppression on the ghrelin system. Public Library of Science 2013-10-09 /pmc/articles/PMC3794018/ /pubmed/24130717 http://dx.doi.org/10.1371/journal.pone.0075560 Text en © 2013 Azushima et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Azushima, Kengo Tamura, Kouichi Wakui, Hiromichi Maeda, Akinobu Ohsawa, Masato Uneda, Kazushi Kobayashi, Ryu Kanaoka, Tomohiko Dejima, Toru Fujikawa, Tetsuya Yamashita, Akio Toya, Yoshiyuki Umemura, Satoshi Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity |
title | Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity |
title_full | Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity |
title_fullStr | Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity |
title_full_unstemmed | Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity |
title_short | Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity |
title_sort | bofu-tsu-shosan, an oriental herbal medicine, exerts a combinatorial favorable metabolic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesity |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794018/ https://www.ncbi.nlm.nih.gov/pubmed/24130717 http://dx.doi.org/10.1371/journal.pone.0075560 |
work_keys_str_mv | AT azushimakengo bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity AT tamurakouichi bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity AT wakuihiromichi bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity AT maedaakinobu bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity AT ohsawamasato bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity AT unedakazushi bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity AT kobayashiryu bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity AT kanaokatomohiko bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity AT dejimatoru bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity AT fujikawatetsuya bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity AT yamashitaakio bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity AT toyayoshiyuki bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity AT umemurasatoshi bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity |